939791-42-1Relevant articles and documents
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs
Gao, Hongying,Wu, Yue,Sun, Yonghui,Yang, Yiqing,Zhou, Guangbiao,Rao, Yu
, p. 1855 - 1862 (2019/11/14)
Focal adhesion kinase (FAK), a cytoplasmic protein tyrosine kinase, exerts kinase-dependent enzymatic functions and kinase-independent scaffolding functions, both of which are crucial in cancer development, early embryonic development, and reproduction. H
Compound for degrading FAK (Focal Adhesion Kinase) protein in targeting manner and application thereof
-
, (2018/12/05)
The invention provides a compound. The compound is a compound shown as a formula I or a stereoisomer, a geometric isomer, a tautomer, nitrogen oxide, hydrate, a solvate, a metabolic product, pharmaceutically acceptable salt or a prodrug thereof: X-Y-Z (formula I), wherein X represents a ligand of FAK protein, Z represents ligand of E3 ligase and Y represents a chain for connecting the X and the Z.
PYRROLOPYRIMIDINES AS FAK AND ALK INHIBITERS FOR TREATMENT OF CANCERS AND OTHER DISEASES
-
, (2012/04/23)
Disclosed are compounds which inhibit the activity of focal adhesion kinase (FAK) and anaplastic lymphoma kinase (ALK), compositions containing the compounds, and methods of treating diseases during which FAK and ALK are expressed. The diseases are, for example, cancers.